Queratal

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Queratal

Quick Facts: Queratal Identity

Property Description
Active ingredient Vitamin A (Retinol, Retinyl Esters, Retinoic Acid)
Form Cream, Gel, Lotion, Capsule, Solution
Pharmacological class Retinoid, Fat-Soluble Vitamin
Common use (General Purpose) Supporting cell differentiation and tissue integrity
Origin Essential nutrient, Natural or Synthetic analog

Queratal: A Retinoid and Fat-Soluble Vitamin

Queratal is fundamentally a targeted therapeutic agent based on compounds related to the essential nutrient, Vitamin A. This medication is chemically classified within the retinoid family and the Fat-Soluble Vitamin class. The active component is a derivative of retinol and provides potent biological activity crucial for numerous physiological functions. Because it is a fat-soluble vitamin derivative, Queratal is metabolized and stored in the body differently from water-soluble supplements, allowing for sustained physiological actions. This medicine helps manage foundational health by regulating how cells mature and grow.

Active Ingredients and Available Forms (Composition and Origin)

The active ingredient in Queratal is a Vitamin A compound, such as Retinyl Esters or the powerful metabolite, Retinoic Acid (Tretinoin). This ingredient can be either naturally derived or synthesized for medicinal use, reflecting its essential nutrient status but high therapeutic potency. The composition includes the active substance combined with a base/vehicle, such as an oily solution, a cream base, or an inert filler for oral capsules. Queratal is commonly found in various dosage forms, including cream, gel, lotion, and capsule, allowing for either topical or systemic delivery depending on the intended site of action.

General Purpose: Cellular Regulation and Tissue Support

The general purpose of Queratal is to regulate the growth, differentiation, and maturation of cells, thereby promoting tissue health. Its physiological action is tied to its role as a gene transcription regulator; the active retinoid compound influences the expression of genes critical for cell development. This mechanism is crucial for maintaining the structural integrity of the skin and mucous membranes, and is also necessary for the proper functioning of the visual system. A typical neutral use scenario for products like Queratal involves supporting the skin’s natural renewal process by driving cellular differentiation.

Regulatory References

  1. National Institutes of Health (NIH) bookshelf

What side effects are possible with Queratal?

Possible Side Effects and Safety Information

The official safety information for Queratal (a retinoid) is categorized by regulatory agencies based on the route of administration, distinguishing between common, localized reactions and rare, systemic risks. Adverse events are grouped by System-Organ Class (SOC) and documented frequency.

Commonly Documented Adverse Reactions

Adverse reactions classified as Very Common (ge 1/10) typically involve the site of application for topical formulations and include erythema (redness), skin peeling or exfoliation, dryness, skin pain, burning, and pruritus (itching). With systemic administration, Very Common events include headache, fever, bone pain, dry skin and mucous membranes, and gastrointestinal effects like nausea and vomiting. Cutaneous irritation often peaks during the initial two weeks of topical therapy.

System-Organ Class Key Adverse Reaction Types
Skin and Subcutaneous Erythema, peeling, dryness, pruritus, hyper/hypopigmentation
General Disorders Fever, malaise, pain, local application site irritation
Nervous System Headache, dizziness, Intracranial Hypertension (Pseudotumour Cerebri)
Metabolism & Nutrition Increased blood triglycerides and cholesterol levels (reversible)

Serious Adverse Reactions and Constraints

Systemic use of Queratal carries the documented risk of serious reactions. These include Differentiation Syndrome (formerly RA-APL Syndrome), a life-threatening complication characterized by acute respiratory distress and multi-organ failure, typically occurring within the first month of treatment. The medication is officially designated as a severe Teratogen when used systemically; this necessitates strict pregnancy prevention protocols for patients of child-bearing potential. Thromboembolic events are also documented. Safety-related restrictions mandate the minimization of UV light exposure (photosensitivity) and frequent laboratory monitoring of liver function and lipids during systemic treatment.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose of Queratal, a retinoid compound, is officially categorized as Acute or Chronic Toxicity. The response to any suspected overdose must be the immediate discontinuation of the agent, and immediate medical attention is required upon suspicion or the appearance of serious symptoms.

Classification Documented Overdose Presentations
Acute Toxicity Nausea, Vomiting, Dizziness, Irritability, Drowsiness, and Severe Headache with signs of Increased Intracranial Pressure [Source 1.1, 1.2]
Chronic Toxicity Hair loss (Alopecia), dry/peeling skin, Hepatomegaly (enlarged liver), bone pain, and development of Pseudotumor Cerebri [Source 1.1, 1.2]

Serious Outcomes and Actions:

  • Mandated Urgent Help: Immediate medical evaluation is required if symptoms like severe headache, vomiting, or visual disturbances develop, as these may signal life-threatening complications.
  • Severe Risks: Chronic overdose carries a regulatory warning for Hepatic Toxicity (potential liver damage) and the possibility of Permanent Central Nervous System (CNS) damage [Source 1.2, 2.1].
  • Antidote and Management: No specific antidote is known for this toxicity. Treatment is strictly symptomatic and supportive, and may include neurological and Liver Function Testing (LFT) monitoring [Source 1.4, 2.1].
  • Population Note: Excessive intake during pregnancy is explicitly associated with a high risk of teratogenicity (severe and irreversible birth defects), an essential warning in official labeling [Source 1.2].

Therapeutic Uses of Queratal

What Queratal Treats: Main Uses and Benefits

Queratal, a therapeutic agent based on Vitamin A compounds, is used across several relevant clinical contexts. This therapeutic use is relevant in conditions where supporting cellular stability is appropriate. The medication is relevant for managing conditions associated with periods of heightened symptoms, nutritional deficiency, and specific serious diseases.

Queratal is commonly applied in addressing acne vulgaris, different forms of psoriasis, the visible effects of photoaging, and, in systemic form, Acute Promyelocytic Leukemia (APL).

Quick Fact: Relief for Symptom Clusters

Queratal supports the management of conditions where symptoms create noticeable physiological strain, specifically those involving scaling and the formation of inflammatory skin lesions. This supportive role may assist with maintaining functional stability, particularly in chronic skin disorders.


The supportive benefit is linked to the medication's capacity to help manage symptom clusters like inflammatory lesions, scaling, and skin roughness. This provides support that contributes to improved day-to-day comfort during chronic phases. In cases of confirmed deficiency, it is considered relevant for managing symptoms such as impaired low-light vision.

“The primary goal of this therapy is to help manage symptoms related to physical discomfort and support functional stability.”

Regulatory References

  1. overview on Tretinoin from the NIH Bookshelf

Eligibility and Restrictions for Use

Queratal, being a retinoid, has strict population-based eligibility rules defined by government regulatory agencies. Use is Contraindicated in women who are pregnant or planning a pregnancy due to the high risk of severe congenital malformations, which is an absolute exclusion criterion for both topical and systemic forms. It is also contraindicated in patients with a known hypersensitivity to retinoids, Vitamin A, or any component of the specific formulation. Systemic (oral) use is prohibited when taking tetracycline antibiotics or therapeutic Vitamin A supplements.

Age-Related Eligibility Status (Based on Official Labeling)
Pediatric (Topical) Indicated for patients ge 12 years of age; Use Not Established in patients below age 12.
Geriatric (Topical) Safety and effectiveness have not been established.

For Lactation, caution should be exercised with the topical form, as it is not known if the drug is excreted in human milk. Nursing must be discontinued before beginning the oral (systemic) form. Furthermore, the topical form should be used with utmost caution on eczematous or sunburnt skin.

What should I know about interactions with other medicines?

Queratal Interactions with other medicines and products

Queratal (tretinoin capsules) is a substrate for the CYP3A enzyme system. The concomitant use of other medicines can impact Queratal's concentration and increase the risk of adverse effects or reduce its effectiveness.

Key Interactions

Interacting Product Category Interaction Mechanism and Result Management Classification
Strong CYP3A Inhibitors Increase Queratal plasma concentration, raising the risk of adverse reactions. Avoid concomitant use if possible.
Strong CYP3A Inducers Decrease Queratal plasma concentration, potentially reducing drug efficacy. Avoid concomitant use if possible.
Products Causing Intracranial Hypertension (e.g., tetracyclines) Increased risk of intracranial hypertension, particularly in pediatric patients. Avoid concomitant use.
Anti-fibrinolytic Agents (e.g., tranexamic acid) Increased risk of fatal thrombotic complications due to additive procoagulant effects. Avoid concomitant use.
Vitamin A Increased risk of vitamin A-related adverse reactions (Hypervitaminosis A). Avoid concomitant use.

Patients should inform their healthcare provider of all prescription medications, over-the-counter products, and supplements they are currently using to ensure a comprehensive review of potential interactions is performed.

Mechanism of Action

Ontology: How Queratal Works

Queratal acts as a regulator of fundamental cell processes by operating within three interconnected mechanistic domains, all strictly focused on gene transcription.


Nuclear Receptor Activation and Transcriptional Control

This domain covers the molecular core of the drug's action: the binding of the active molecule, Retinoic Acid, to Retinoic Acid Receptors (RARs) and Retinoid X Receptors (RXRs). This interaction forms a functional heterodimer that acts as a transcriptional modulator on the DNA, initiating genetic cascades that determine cell function.


Modulation of Epithelial Cell Life Cycle

By modulating the expression of genes critical for growth and maturation, the mechanism works to modulate the ratio between cell proliferation and differentiation. This fundamental cellular reprogramming influences the rate and differentiation of cell turnover, such as keratinocytes, which affects the processes that determine tissue structure and barrier formation.


Regulation of Tissue Remodeling Pathways

The drug's mechanism also influences the tissue's supporting structure by regulating the output of enzymes that control the Extracellular Matrix (ECM). Specifically, it suppresses the activity of tissue-degrading enzymes while influencing the synthesis of essential structural components, thereby contributing to the remodeling and modulating the structural properties of the affected tissue architecture.

Dosage and Administration Information

Queratal is administered via two distinct official routes, with the specific regimen determined by the therapeutic context. The drug's use is strictly defined for both topical (dermatological) and oral (systemic) delivery, including specific dosing, frequency, and preparation rules.

Instruction Parameter Topical Administration (Cream, Gel, Solution) Oral Administration (Capsule)
Route and Frequency Applied directly to the skin, once daily, typically in the evening. Systemic administration, taken twice daily as two evenly divided portions.
Dosing Rule Application of a thin layer over the affected area (in strengths ranging from 0.01% to 0.1%). Calculated based on Body Surface Area (BSA) at 45 mg/m^2/ day.
Administration Conditions Apply to clean, dry skin, ensuring strict avoidance of the eyes, mouth, and mucous membranes. Must be taken with a meal for proper absorption, and capsules must be swallowed whole.
Course and Duration Continuous use is often long-term, potentially requiring up to six months for full effect. Approved for patients 12 years of age and older. Treatment is generally continuous until complete remission is documented, typically with a maximum course duration of 90 days.

The official guidelines establish that oral administration requires specialist supervision and that patients should not use excessive amounts of the topical product, as this will not accelerate results. The instructions mandate that if a topical dose is missed, it should be skipped, and the next dose should be applied at the usual time, without attempting to double the amount.

Recent Clinical Evidence

Queratal: Recent Clinical Evidence

This section outlines the research base for Queratal, describing the types of studies that have been conducted and the research areas that remain uncertain.


Evidence for Topical Use in Acne Vulgaris and Photoaging

Research on Skin Aging and Photodamage

Queratal was evaluated in double-blind, vehicle-controlled Randomized Controlled Trials (RCTs) exploring its use in conditions associated with functional limitations and visible changes to the skin. Research examined outcomes related to physical discomfort, such as clinical scores for fine and coarse facial wrinkles, and assessment of outcomes linked to inflammatory or irritative states, such as mottled hyperpigmentation. Findings describe patterns observed in the studies, which included measurements of changes in clinical appearance scores over observation periods.

Research on Acne Lesions

Queratal was evaluated in studies using multiple short-term RCTs and systematic reviews, relevant in trials assessing short-term or episodic symptom patterns of acne. Outcomes measured included lesion counts and Investigator Global Assessment (IGA) scores. Studies report how symptoms evolved in the observed populations, noting measurements of a change in total acne lesion count over time when comparing the medicine to a non-active vehicle. Certainty remains low for certain claims due to documented inconsistencies between trial evidence.

Evidence for Systemic Use in Acute Promyelocytic Leukemia (APL)

This section will outline the structure of the clinical evidence, describing the Randomized Phase III Clinical Trials and observational studies that have investigated outcomes related to Complete Remission (CR) rates and survival data for APL patients. The results apply only to the populations studied in highly controlled environments. Data for certain groups, such as elderly patients, remain insufficient for independent conclusions. Long-term effects are not fully established across all indications and patient populations.

Research Gaps and Areas of Uncertainty

Across the research landscape, the evidence quality varies across studies, and comparative evidence is lacking, especially for systemic uses in chronic conditions. Research provides context but not individual predictions; study results reflect the specific conditions under which they were conducted. Evidence highlights what is known — and what is still uncertain.

Key Studies & References

  1. Tretinoin - StatPearls
  2. Biochemistry, Fat Soluble Vitamins

Frequently Asked Questions (FAQ)

Common questions about Queratal (FAQ)


Q: Is Queratal the same kind of medicine as [similar drug name]?

A: Official documents classify Queratal as a retinoid, which is a class of compounds chemically related to the essential nutrient Vitamin A. This classification dictates the medicine’s primary mechanism of action in regulating cell growth and differentiation. The classification indicates a shared biological foundation, but each retinoid compound has its own distinct therapeutic uses and regulatory safety profile.

Q: How quickly should I expect to see an effect from Queratal?

A: For the topical formulation, initial improvements are typically observed after six to eight weeks of continuous use. Achieving the full therapeutic effect may require up to six months of treatment. Official information indicates that consistent application over the defined period is necessary to see the intended results.

Q: Do the side effects of Queratal go away after a while?

A: The localized side effects common with the topical formulation, such as redness, peeling, and irritation, often peak during the initial two weeks of therapy before potentially subsiding. Systemic adverse effects reported for the oral use are typically described in the official label as not permanent or irreversible.

Q: Is Queratal safe to use for a long time?

A: The topical formulation is approved for continuous, long-term administration. In contrast, the oral systemic formulation typically has a maximum course duration, such as 90 days. Official research indicates that the full range of long-term effects across all patient populations and indications is not fully established.

Q: Can older adults use Queratal safely?

A: Official labeling states that the safety and effectiveness of the topical formulation have not been established in geriatric patients. Data regarding the oral formulation in elderly patients remains insufficient for independent conclusions. Due to this limited data, assessment by a specialist is necessary for the use of Queratal in older adults.

Q: Does Queratal have any listed interactions with herbal supplements?

A: The official prescribing information for Queratal stresses the importance of discussing all products, including herbal supplements and nonprescription medicines, with a healthcare provider. This comprehensive review is necessary to identify and manage any potential interaction risk.

Q: Can I take Queratal with my daily multivitamins?

A: The official label advises caution regarding multivitamins, particularly those containing Vitamin A. Because Queratal is a Vitamin A derivative, taking additional Vitamin A supplements is strictly contraindicated with the oral formulation and should be avoided with topical use due to the risk of additive toxicity. Disclosure of the multivitamin’s exact composition to a healthcare provider is essential.

Q: Can Queratal cause trouble sleeping?

A: Official adverse event reports indicate that trouble sleeping, medically known as insomnia, has been reported in some patients using the oral systemic formulation. This is listed as a nervous system-related adverse reaction.

Q: Can I take pain relievers while I am using Queratal?

A: Potential interactions between Queratal and some over-the-counter pain relievers depend on the specific pain reliever's chemical class and dose. For this reason, it is important that a healthcare provider maintains a complete record of all concomitant prescription and nonprescription medications to screen for potential interaction risks.

Q: Are there any foods or drinks I should avoid while on Queratal?

A: Official warnings are primarily related to alcohol and Vitamin A intake. Alcohol consumption is linked to a potential increase in the risk of high cholesterol and triglyceride levels with the oral formulation. Topical formulations should also avoid contact with certain skin products containing high concentrations of alcohol, spices, or lime.

Q: Is Queratal suitable for people who have kidney issues?

A: For the topical use, official documents note that specific dosage adjustment is typically not required for patients with kidney issues. However, the oral formulation has reported instances of chronic kidney disease as an adverse reaction, and carries the risk of multi-organ failure associated with Differentiation Syndrome.

Q: Can people with high blood pressure take Queratal?

A: Official adverse event reports indicate that hypertension, or high blood pressure, has been reported as a cardiovascular side effect in patients using the oral systemic formulation. Patients who have high blood pressure should seek medical guidance regarding the documented risk before use.

Q: Will Queratal affect my ability to drive or operate machinery?

A: The official product information for the oral formulation lists nervous system side effects such as dizziness and confusion. The presence of these effects may impair judgment or motor skills, and the regulatory label cautions against driving or operating machinery if affected.

Q: Do I need to change my diet while I'm on Queratal?

A: Patients on the oral formulation may potentially need to adjust their diet because the medicine can cause increased blood levels of triglycerides and cholesterol. Regulatory safety guidelines require frequent laboratory monitoring of the patient's lipid profile, and any changes to diet would be based on the findings from this regular monitoring.

Q: Can I stop taking Queratal suddenly if I feel better?

A: The official guidance advises against abrupt cessation of Queratal unless specifically instructed by a healthcare provider. Stopping the medication before the full prescribed course is completed may lead to a higher risk of the treated condition relapsing or returning.

Q: Is Queratal available over the counter anywhere?

A: Official regulatory bodies classify Queratal, which contains the active ingredient Tretinoin, as a prescription-only medicine (POM/Rx-only). This legal classification means it requires a prescription from an authorized healthcare provider and is not available for purchase over the counter.

Q: If I have a mild reaction, should I still continue taking Queratal?

A: Mild, localized reactions like redness and dryness are common and expected when starting topical therapy. The official label provides guidance that these mild reactions may be managed by a temporary reduction in frequency or discontinuation until irritation subsides. Persistent or severe irritation is a factor that should be assessed by a healthcare provider.

Q: How long does the effect of a Queratal dose usually last?

A: The elimination half-life of the active ingredient is a measure of how quickly the medicine is removed from the body, and it is reported to be short. Official pharmacokinetic data indicates the half-life typically ranges from 0.5 to 2 hours, suggesting a rapid clearance from the bloodstream after a dose.

Q: Is it normal to feel a little tired when first starting Queratal?

A: Fatigue and general weakness have been reported as common, drug-related toxicities in patients receiving the oral systemic formulation. If these effects are noted, they are documented in the official adverse events listings.

Q: What happens if Queratal is taken with alcohol?

A: Official drug information categorizes alcohol consumption as a moderate interaction, primarily with the oral formulation. This is due to a potential increase in the risk of high cholesterol and/or triglycerides (hyperlipidemia) when the two are used concomitantly.

Q: What are the possible withdrawal effects of stopping Queratal?

A: There are no specifically defined 'withdrawal' symptoms listed in official documents. However, official guidance notes that stopping the medication before the full prescribed course is completed may lead to a higher risk of the condition returning or relapsing.

Q: Is there an official patient leaflet for Queratal I can read?

A: Yes, all prescription medicines approved by regulatory bodies, such as the FDA and EMA, are required to be supplied with official patient information. This document is typically called a Patient Information Leaflet (PIL) or Patient Medication Information (PMI) and contains detailed, official drug information.

How should Queratal be stored and disposed of?

How to Store and Dispose of Queratal?

Official regulatory guidelines define specific storage and disposal requirements for this medicine.

Storage Requirements

Queratal must be stored in its closed container at room temperature, securely away from excess heat, moisture, and direct light. It is essential to keep the medicine from freezing. For the gel formulation, a flammability warning applies, requiring it to be kept away from fire or excessive heat sources. Always store Queratal in a safe, up-and-away location, ensuring it is out of the reach of children.

Disposal Requirements

Do not keep outdated or no longer needed medicine. To ensure proper and safe disposal, consult a healthcare professional or pharmacist for instructions on how to discard any unused medicine, complying with local and federal regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Queratal found in:

A-Z Index: